Back to results

CompletedPhase 3

Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry

NCT02851745

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Azienda Ospedaliera Papa Giovanni Xxiii

Bergamo, BG, Italy

+18 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2015-07
Enrollment: 188 participants
Sponsor: Heart Care Foundation
Purpose: treatment

Locations (19)

Azienda Ospedaliera Papa Giovanni XxiiiBergamo, BG, Italy
P.O. Garibaldi-NesimaCatania, CT, Italy
Ospedale Casa Sollievo Della SofferenzaSan Giovanni Rotondo, FG, Italy
Ospedale Villa ScassiGenova, GE, Italy
Iclas-Istituto Clinico Ligure Alta Spec.Rapallo, GE, Italy
Ospedale San Giuseppe Da CopertinoCopertino, LE, Italy
Ospedale San RaffaeleMilan, Lombardy, Italy
Policlinico G. MartinoMessina, ME, Italy
Irccs Policlinico MultimedicaSesto San Giovanni, MI, Italy
A.O. Santa Croce e CarleCuneo, Piedmont, Italy
Ospedale Sandro PertiniRoma, RM, Italy
Ospedale MaggioreChieri, TO, Italy
Ospedale MaurizianoTorino, TO, Italy
Azienda Ospedaliera Santa MariaTerni, TR, Italy
Aas 1 TriestinaTrieste, TS, Italy
Centro Cardiologico MonzinoMilan, Italy
Aorn Osp. Dei Colli- Po Vincenzo MonaldiNaples, Italy
Seconda Universita' Di NapoliNaples, Italy
Casa di Cura Villa BiancaTrento, Italy

Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry — TrialFind